Last reviewed: July 2, 2026
Last updated: July 2, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide therapy, the active ingredient in Wegovy®, works through a once-weekly injection protocol that has been studied extensively in clinical trials. Many people wonder whether they can extend their injection interval to every two weeks as their treatment progresses. Understanding how semaglutide dosing actually works helps you make informed decisions with your healthcare provider about your personalized weight loss plan.
Standard Semaglutide Injection Dosing Frequency
Semaglutide is designed and studied as a once-weekly injectable medication for weight management. The standard protocol starts patients at a lower dose and gradually increases it over approximately 16 weeks, with one injection given every seven days. This consistent weekly rhythm allows semaglutide to maintain steady levels of the GLP-1 hormone mimic in your bloodstream, which helps regulate appetite and blood sugar control. The FDA-studied protocols for weight loss used this weekly schedule throughout clinical trials, making it the evidence-based foundation for treatment.
Deviating from the once-weekly schedule, including extending to every two weeks, falls outside the established dosing guidelines and may reduce medication effectiveness. Your body processes semaglutide systematically, and the drug's half-life—roughly one week—means that spacing doses further apart could create gaps in therapeutic coverage. If you experience side effects or believe your current schedule isn't working, discussing alternatives with your prescribing provider is more effective than adjusting timing on your own.
Why Weekly Injections Maintain Consistent Results
The weekly injection schedule exists because GLP-1 receptor agonists work best when your body receives consistent, predictable doses of the medication. When you inject once per week, you maintain a stable concentration of semaglutide in your system, which keeps appetite suppression steady and prevents fluctuations in hunger signals. Studies show that this consistency leads to more reliable weight loss results compared to irregular dosing patterns. Skipping a week or extending your interval can create a period where the medication's effects weaken, potentially triggering increased appetite and cravings.
From a scientific standpoint, semaglutide's pharmacokinetics—how your body absorbs, distributes, and eliminates the drug—depend on regular weekly dosing to achieve predictable blood concentrations. If you move to a biweekly schedule, you would be doubling each dose volume, which changes how your body processes the medication and may increase your risk of gastrointestinal side effects. Healthcare providers design treatment schedules around published clinical trial data, and biweekly dosing lacks this evidence base for safety and efficacy.
What to Do If Weekly Injections Feel Like Too Much
If weekly injections feel burdensome or you're experiencing side effects, your prescribing provider has several evidence-based options that don't involve skipping weeks. You can pause treatment temporarily to let side effects subside, adjust your current dose to a lower level within the established protocol, or switch to an oral semaglutide formulation if injection fatigue is the primary concern. Some patients benefit from slower dose escalation, which extends the ramp-up period and reduces the intensity of adjustment symptoms. PlexusDx offers compounded semaglutide injections starting at $149 per month, with the flexibility to work with your provider on a personalized dosing schedule that fits your needs.
Another option gaining recognition is microdosing protocols, which begin at lower initial doses and increase more gradually over extended timelines. This approach can reduce early side effects while still delivering therapeutic benefits. PlexusDx offers a Microdose GLP-1 Protocol at $129 per month for patients who benefit from this gentler introduction to semaglutide therapy. Your provider can also explore whether genetic factors—like variants in your GLP1R gene—might predict how your body responds to standard versus modified dosing approaches.
Understanding Semaglutide Dose Adjustments vs. Dosing Frequency
It's important to distinguish between adjusting your dose—the amount of medication per injection—and adjusting your frequency, which is how often you inject. Dose adjustments happen within the standard weekly framework and are a normal part of treatment. Your provider increases your dose incrementally while keeping the weekly injection schedule steady, based on how your body responds and how well you tolerate side effects. This is entirely different from changing when you inject, such as moving to biweekly dosing, which lacks clinical trial support and may compromise results.
PlexusDx emphasizes the marketing principle that 'your dose may need to go up, your price won't'—meaning that dose escalation within the weekly protocol doesn't increase your monthly cost. Whether you're at your starting dose or at a higher maintenance dose with weekly injections, PlexusDx compounded semaglutide remains one flat price per month. If dose changes or frequency questions arise, your PlexusDx provider team can discuss whether other formulations, like oral semaglutide or our GLP-Squared dual-compound options, might better suit your preferences and tolerance profile.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take Wegovy® every two weeks instead of weekly?
No. Semaglutide is designed and studied for once-weekly injection, and extending the interval to biweekly falls outside established clinical guidelines. This timing change could reduce medication effectiveness and create gaps in appetite suppression. If weekly injections are challenging, discuss alternatives like oral formulations or dose adjustments with your prescribing provider.
What happens if I skip a week of semaglutide injections?
Skipping a week allows semaglutide levels to drop below therapeutic concentration, potentially triggering increased hunger and cravings. This may slow or reverse your weight loss progress and make it harder to get back on track when you resume weekly dosing. If you need to pause treatment, consult your provider about safe ways to restart rather than simply skipping doses.
How much does compounded semaglutide cost with PlexusDx?
PlexusDx compounded semaglutide injections start at $149 per month with a flat monthly price regardless of your dose level. No insurance is required, and HSA and FSA funds are eligible for use. PlexusDx serves all 50 states and uses only licensed 503A compounding pharmacies.
Are there other options if I don't want weekly injections?
Yes. PlexusDx offers oral semaglutide starting at $249 per month, which you take daily instead of injecting weekly. There's also a Microdose GLP-1 Protocol at $129 per month for slower, gentler dose escalation, and GLP-Squared dual-compound options combining semaglutide and tirzepatide for enhanced results.
How does the PlexusDx Precision Peptide Genetic Test help with semaglutide dosing?
The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes key genetic variants like GLP1R rs6923761, which influences how your body's GLP-1 receptors respond to semaglutide. Understanding your genetic profile helps your provider predict your likely response to standard dosing and may guide whether you'd benefit from microdosing, higher doses, or alternative compounds like tirzepatide.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss with Celiac Disease: Can Someone with Celiac Take Ozempic?
Ozempic Dosing Explained: How High of a Dose Can You Take?